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Background information. Cell fusion is known to underlie key developmental processes in humans and is postulated
to contribute to tissue maintenance and even carcinogenesis. The mechanistic details of cell fusion, especially
between different cell types, have been difﬁcult to characterize because of the dynamic nature of the process
and inadequate means to track fusion products over time. Here we introduce an inducible system for detecting
and tracking live cell fusion products in vitro and potentially in vivo. This system is based on BiFC (bimolecular
ﬂuorescence complementation) analysis. In this approach, two proteins that can interact with each other are joined
to fragments of a ﬂuorescent protein and are expressed in separate cells. The interaction of said proteins after cell
fusion produces a ﬂuorescent signal, enabling the identiﬁcation and tracking of fusion products over time.
Results. Long-term tracking of fused p53-deﬁcient cells revealed that hybrid cells were capable of proliferation. In
some cases, proliferation was preceded by nuclear fusion and division was asymmetric (69%+ −2% of proliferating
hybrids), suggesting chromosomal instability. In addition, asymmetric division following proliferation could give rise
to progeny indistinguishable from unfused counterparts.
Conclusions. These results support the possibility that the chromosomal instability characteristic of tumour cells
may be incurred as a consequence of cell fusion and suggest that the role of cell fusion in carcinogenesis may have
been masked to this point for lack of an inducible method to track cell fusion. In sum, the BiFC-based approach
described here allows for comprehensive studies of the mechanism and biological impact of cell fusion in nature.
Introduction
Fusion between cells of the same type has been ob-
served and extensively studied in a variety of tissues
including muscle, bone, liver and placenta (Chen
and Olson, 2005; Ogle et al., 2005). In these tis-
sues,fusionproductsarebelievedtopossessenhanced
functions compared with their unfused progenit-
ors. For example, when the trophoblast cells of the
1To whom correspondence should be addressed (email ogle@wisc.edu).
Key words: cell fusion, bimolecular ﬂuorescence complementation (BiFC), live
cell imaging, stem cell, cancer.
Abbreviations used: Bach2, BTB and CNC homology 1, basic leucine zipper
transcription factor 2; BiFC, bimolecular ﬂuorescence complementation;
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expressed sequence tag; PEG, poly(ethylene glycol); YFP, yellow ﬂuorescent
protein.
placenta fuse to form the syncytiotrophoblast, the
syncytiotrophoblast is better able to transport nu-
trients and hormones across the maternal–fetal bar-
rier than unfused trophoblasts (Hoshina et al., 1982;
Benirschke, 1995). Failure of syncytiotrophoblast
formation is linked to complications of pregnancy,
suchaspre-eclampsia(Johansenetal.,1999;Redman
and Sargent, 2000). Fusion between cells of different
types has also been demonstrated and, in some cases,
results in reprogramming of cellular gene expression.
For example, fusion of human ﬁbroblasts and murine
muscle cells gave rise to fusion products in which
human muscle genes are expressed from the ﬁbro-
blast genome (Blau et al., 1983). The modiﬁcation
of cell fate by fusion was believed by some to be
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limited to cultured cells. However, stem cell trans-
plantation for therapeutic purposes led to the discov-
ery that stem cells or their progeny can fuse with a
variety of somatic cells in vivo and that fusion affects
stemcelldifferentiation(Alvarez-Doladoetal.,2003;
Vassilopoulos et al., 2003; Wang et al., 2003;
Camargo et al., 2004; Nygren et al., 2004; Ogle
et al., 2004; Shi et al., 2004; Ishikawa et al., 2006;
Johansson et al., 2008). Intriguingly, some observa-
tions suggest that cell fusion is rate-limiting in the
progression of some cancers (Parris, 2005; Duelli and
Lazebnik,2007).Thuscellfusioncouldbeimportant
for development, tissue repair and pathogenesis.
Given the potential signiﬁcance of cell fusion, it
is surprising that basic aspects of cell fusion are still
largely unknown. A hindrance to progress in this
area is the lack of appropriate technology to accur-
ately identify fusion products and to track them over
time. Insufﬁcient technology has prevented investig-
ation of the prevalence of cell fusion or its functions.
Thus technical advances in this area can contribute
to a better understanding of the fundamental char-
acteristics of cell fusion. Such improved approaches
could lead to identiﬁcation of the signals that trigger
fusion, the cell surface proteins that mediate fusion
and the mechanism(s) that reprogramme and deter-
mine the functions of hybrid cells.
Two primary methods are currently employed to
detect and track the fusion between living cells.
Firstly, cell fusion can be detected using ﬂuores-
cent dyes. Once inside living cells, these dyes re-
act with intracellular components (i.e. thiol groups,
amine groups) to produce cells that are ﬂuorescent.
Different dyes are used to label each fusion partner
and fusion products are detected based on emissions
from both ﬂuorophores. This method is appropri-
ate for short-term in vitro studies; however, in vivo
studies are difﬁcult and the ﬂuorescence signal is
lost over time. In addition, other processes can res-
ult in membrane transfer between cells, potentially
leading to misidentiﬁcation of fusion events. Fusion
events can also be identiﬁed by labelling prospective
fusion partners using ﬂuorescent proteins [i.e. CFP
(cyan ﬂuorescent protein) or YFP (yellow ﬂuorescent
protein)]. This method allows long-term tracking of
fusionproducts.However,itcanbedifﬁculttodistin-
guish fusion products from cells whose ﬂuorescence
signalsoverlapindenselypackedcellsincultureorin
tissue. In addition, it may be possible for the signal
to be transferred to cells via uptake of cellular debris
in the absence of fusion. Secondly, cell fusion can be
detected by the complementary actions of proteins:
most commonly, the lacZ system (Mohler and Blau,
1996) and the Cre–LoxP system (Alvarez-Dolado
et al., 2003; Ogle et al., 2005). With lacZ gene com-
plementation, the gene is dissected into two frag-
ments and each fragment is introduced into each fu-
sion partner. Enzymatic activity is produced on con-
vergent expression of the two distinct mutant lacZ
peptides within single cells or on fusion of cells ex-
pressing such mutants. Unfortunately, detection of
lacZ complementation requires addition of a sub-
strate and, hence, is not favourable for long-term
tractability. With Cre–LoxP gene complementation,
onefusionpartnerconstitutivelyexpressesCrerecom-
binaseandtheotherfusionpartnerharboursareporter
gene placed adjacent to a stop codon ﬂanked by LoxP
sequences. When exposed to the Cre protein via cell
fusion the LoxP and stop signals are excised and the
reportergeneisexpressed.Thisinduciblemethoden-
ables detection of only true fusion events in vitro and
in vivo. However, generation of the signal requires
time for excision of the stop codon and subsequent
transcription and translation of the reporter. This
delay limits the ability to study events immediately
after cell fusion. Thus, although some progress has
beenmadetomonitorcellfusioninlivingcells,there
is a paucity of effective means to detect and track fu-
sion products quickly and reliably in vitro and in vivo.
Here we introduce a new approach to detect and
track cell fusion of living cells. The approach is
based on BiFC (bimolecular ﬂuorescence comple-
mentation), a method originally designed to study
protein–proteininteractionsinlivingcells(Huetal.,
2002). BiFC is based on the observation that frag-
ments of a ﬂuorescent protein can be genetically
dissected into two non-ﬂuorescent fragments. Each
fragment is joined to two separate proteins and in-
teraction between these two proteins facilitates the
maturation of ﬂuorescent protein assembled from
the ﬂuorescent fragments. The location and intensity
of BiFC signals have been used to study interactions
among a variety of proteins including nuclear, ubi-
quitin family, membrane, enzymatic and signalling
proteins (Kerppola, 2006). Here we use the unique
properties of BiFC analysis to detect and track cell
fusion events. In brief, any pair of chosen proteins
known to interact with each other can be linked to
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Figure 1 Representation of BiFC analysis adapted to
detect cell fusion
Two cell populations (A and B) are modiﬁed to express non–
ﬂuorescent fragments of ﬂuorescent proteins (YFP) joined to
proteins that can interact with each other. If a cell of popula-
tion A fuses with a cell of population B, the two proteins can
interact with each other and produce a ﬂuorescent signal.
complementary, non-ﬂuorescent fragments and ex-
pressed in separate cell populations (Figure 1). In the
event of cell fusion, cellular components mix, allow-
ing the two non-ﬂuorescent counterparts to interact
and form a ﬂuorescent signal. Due to the absolute
requirement for both fragments to form a ﬂuorescent
complex, the incidence of false-positives is virtually
non-existent and ﬂuorescent signals can be readily
detected via either ﬂuorescence microscopy or ﬂow
cytometry. Since the coding regions of the two fusion
proteinsarealsobroughtintothesamecellonfusion,
the ﬂuorescence intensity increases over time, allow-
inglong-term,live-cellstudies.Finally,theavailabil-
ity of databases of established protein–protein inter-
actions (such as http://mint.bio.uniroma2.it) allows
great ﬂexibility in coupling protein interactions of
interest with fusion events.
Results
An inducible signal for cell fusion using BiFC
analysis
To test whether BiFC could be used to detect cell fu-
sion,wetestedwhetherﬂuorescentproteinfragments
expressed in different cells could form BiFC com-
plexes after cell fusion. To this end, COS-1 cells were
seeded on to two wells that were separately transfec-
ted with plasmids encoding VN-Histone H3.1 (VN-
H3.1)andYC-HistoneH3.1(YC-H3.1)respectively.
VN-H3.1 refers to a plasmid encoding residues 1–
172 of the Venus ﬂuorescent protein joined to His-
tone H3.1, and YC-H3.1 refers to another plasmid
encoding the complementary residues 173–238 of
YFP joined to Histone H3.1. A nuclear BiFC sig-
nal was desirable for initial experiments, since the
presence of two or more nuclei at early time points
after initiation of fusion supports the likelihood that
the signal detected is indeed indicative of cell fu-
sion. Histone H3.1 was selected since two molecules
of Histone H3 are known to participate in the form-
ation of a Histone tetramer with Histone H4. This
tetramercansubsequentlyformanoctamerwithHis-
tones H2A and H2B and is eventually incorporated
stably into chromatin and so detected in the nucleus
(Verreault, 2000). After transfection, equal numbers
of cells in the two wells were co-cultured with cells
expressing the complementary YFP fusion protein.
PEG [poly(ethylene glycol)] was applied to the co-
cultured cells to induce fusion, and the ﬂuorescence
of cells cultured in the presence and absence of PEG
was compared. As a control, equal numbers of cells
(and the same total number of cells as above) that
expressed only VN-H3.1 or YC-H3.1 were cultured
in the presence of PEG. Cells with detectable ﬂuores-
cence were counted 1, 3, 6, 9 and 24 h after PEG ap-
plication using ﬂuorescence microscopy (Figure 2d).
Cells containing multiple ﬂuorescent nuclei were ob-
served in the co-cultures that expressed both VN-
H3.1 and YC-H3.1 treated with PEG (Figures 2a–
2c). These presumably reﬂect the fusion of multiple
cells, including at least one cell from each popula-
tion. As expected, the ﬂuorescence was typically nuc-
lear (Figures 2a–2c) and ﬂuorescent cells were dis-
tributed throughout the culture dishes (Figures 2d
and 2e). Control cells that were co-cultured in the
absence of PEG produced less than 1% of the num-
ber of ﬂuorescent cells observed in cultures treated
with PEG to induce cell fusion. These control cells
contained two or more nuclei, presumably reﬂecting
spontaneous fusion among COS-1 cells. No ﬂuores-
cencewasdetectedincontrolcellsthatexpressedonly
VN-H3.1 or YC-H3.1 treated with PEG. These res-
ultsdemonstratethatBiFCcomplexeswereproduced
on co-culture of cells that expressed complementary
ﬂuorescent protein fragments by a process that was
dramatically enhanced by PEG treatment, consistent
withspeciﬁcdetectionofcellfusionbyBiFCanalysis.
To determine how soon BiFC signals could be de-
tected after PEG-induced fusion and to establish the
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Figure 2 Validation of the BiFC approach to detect cell fusion
Two populations of COS-1 cells were transfected overnight with VN-Histone H3.1 and YC-Histone H3.1 respectively. The two
populations of cells were then plated together one day prior to induction of fusion by PEG1500. (a–e) Typical BiFC fusion
signals. Fusion signals (BiFC, green) were detected by ﬂuorescence microscopy and images were obtained at high (a)a n dl o w
magniﬁcation (d). Histone H3.1 was localized to the nucleus (b, Hoechst 33142 stain, blue; c, e, a merge with phase contrast). (f)
Kinetic analysis of BiFC fusion signals. Two populations of COS-1 cells were transfected with plasmids encoding BiFC partners in
the presence or absence of PEG1500. In addition, two populations of COS-1 cells were transfected with the same BiFC complex
(i.e. VN-Histone H3.1+VN-Histone H3.1 or YC-Histone H3.1+YC-Histone H3.1). The number and location of cells per well
with fusion signals were counted over a period of 24 h after fusion was induced. Three wells were counted for each condition.
The mixture containing both BiFC partners induced to fuse via PEG showed the most dramatic increase in number of signals
over time. In contrast, cell populations containing only one BiFC partner (i.e. VN- or YC-Histone H3.1) showed no formation
of BiFC signals. (g) Time-lapse imaging of BiFC fusion signals. Cells were prepared as above and images were acquired after
PEG-induced fusion at a frequency of 1/10 min over a period of 12 h. The upper panels show fusion signals and the lower panels
show the same signals merged with a corresponding phase image. Scale bars in (a–g), 20 μm.
abilityofthisapproachtotrackproductsofcellfusion
over time, we imaged BiFC complex formation im-
mediately after application of PEG using time-lapse
microscopy imaging. Fluorescence was typically de-
tected within 30 min after PEG treatment and in-
creased in intensity over time. This increase was
observed in spite of photo-bleaching caused by se-
quential imaging. A representative result is shown
in Figure 2(g) (see also Supplementary Movie S1
at http://www.biolcell.org/boc/102/boc1020525add.
htm). The delay in the detection of cell fusion likely
reﬂects the time required for the two non-ﬂuorescent
fragments to produce the mature ﬂuorophore (Kerp-
pola, 2006). However, signal formation might also
require de novo protein synthesis after fusion. To test
this possibility, the pattern of signal expression in
fusion products was monitored over time in the pres-
ence of a protein synthesis blocker, cycloheximide.
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Figure 3 BiFC partners synthesized prior to cell fusion are able to form fusion signals
Two populations of COS-1 cells were transfected with plasmids encoding either VN-CBX2 or YC-Histone H3.1, one day prior
to mixing. In addition, a plasmid encoding CFP–Histone H2A (red) was co-transfected with VN-CBX2. At 90 min prior to
PEG-induced fusion, co-cultured cells were treated with cycloheximide, a chemical blocker of protein synthesis. Time-lapse
imaging was used to track fusion products after application of PEG. Shown is one cell with two nuclei, i.e. the product of one
fusion event. Fusion signals (formed by pre-existing BiFC partners) were found in one nucleus ﬁrst (arrow, from 2 h 30 min to 5 h
50 min after application of PEG). On removal of cycloheximide, new signals (generated as a consequence of newly synthesized
BiFC proteins) formed within both nuclei including the partner nucleus (arrowhead). Times shown in white indicate the time
period after application of PEG1500, and times shown in black indicate the time period after removing cycloheximide. (a)B i F C
signals; (b) CFP signals corresponding to nuclei of fusion partner containing VN-CBX2; (c) YFP/CFP merge; (d) phase contrast
at close to 150 min after application of PEG; (e) quantitative analysis of BiFC ﬂuorescence intensity over time. Zero time in the
scatter plot corresponds to the ﬁrst image in (a) (2 h 30 min after PEG treatment); the 210 min in the scatter plot corresponds to
removal of cycloheximide. Exposure time was shortened after removal of cycloheximide to prevent overexposure. Scale bars,
10 μm.
COS-1 cells separately expressing VN-CBX2 (chro-
mobox protein homologue 2), a protein known to
interact with Histone H3.1 and YC-Histone H3.1
were co-cultured (Vincenz and Kerppola, 2008). Co-
cultures were treated with cycloheximide for 90 min
prior to and after PEG-induced fusion. One fusion
event with two participating nuclei is shown in
Figure 3. A small amount of CFP–Histone H2A
(red, Figures 3b and 3c) was co-expressed in COS-
1 cells carrying VN-CBX2 so that nuclei of this
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Figure 4 Comparison of the BiFC analysis of cell fusion with alternative methods to detect hybrid cells
TwopopulationsofCOS-1cellsweretransfectedwithCFP–c1(red–wholecell)andYFP–CBX5(green–nucleus)respectively.The
two populations were co-cultured overnight and then exposed to PEG to induce fusion. Putative fusion products should contain
both CFP and YFP signals. Such double-positive cells were identiﬁed and tracked over time using ﬂuorescence microscopy.
(a) Tracking of a CFP+/YFP+ fusion event. A white arrow denotes a typical putative fusion product containing both red and green
signals. Over time, a multinucleate entity forms, conﬁrming a fusion event. (b, c) Tracking of a false-positive CFP+/YFP+ fusion
event. A white arrow denotes a typical putative fusion product containing both red and green signals. However, over time the
red and green signals separate, indicating that the signals were overlapping and not fused. The last panel of each series shows
a merge of CFP/YFP ﬂuorescence with phase contrast. Scale bars in (a–c), 20 μm.
population could be discerned in the absence of or
with a delayed BiFC signal. BiFC signals were ﬁrst
formed within one nucleus (arrow) even in the pres-
ence of cycloheximide, conﬁrming that BiFC pro-
teins existing prior to the induction of cell fusion
can participate in and are sufﬁcient to gener-
ate a BiFC signal (Figure 3a). After removal of
the cycloheximide, BiFC complexes formed also
in the nucleus that encoded VN-CBX2 (arrow and
arrowhead).ThefactthatBiFCcomplexesformedun-
equally within the two nuclei while protein synthesis
was blocked suggests that the transfer of YC-H3.1
and VN-CBX2 between the two nuclei occurs at un-
equal rates. This could be attributed at least in part
to the distinct mobilities of Histone H3.1 and CBX2
fusions (Ren et al., 2008). Thus proteins produced by
cellspriortocellfusioncanproduceBiFCcomplexes,
obviating the need for fusion protein synthesis in the
hybrid cell for detection of cell fusion.
Comparison with existing methods to monitor cell
fusion in living cells
Cell fusion can be monitored using cytoplasmic dyes
or by expressing reporter genes (i.e. green ﬂuorescent
protein, YFP and CFP) in fusion partners and track-
ing double-labelled cells (i.e. fusion products) over
time. To test the speciﬁcity and sensitivity of this
label approach compared with the BiFC, two pop-
ulations of COS-1 cells were transfected separately
with CFP (whole cell localization) or YFP–CBX5
(nuclear localization). After PEG-induced fusion, op-
tical ﬁelds containing double-labelled cells (i.e. pu-
tativefusionevents)werechosenandtheseﬁeldswere
tracked over time using ﬂuorescence time-lapse mi-
croscopy.Multiple‘putative’fusioneventswereiden-
tiﬁed(i.e.onenuclearYFPsignalsurroundedbyCFP
signal), many of which were bona ﬁde fusion events
(i.e. YFP signal surrounded by CFP signal persist-
ing over time; Figure 4a). However, false-positive
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Figure 5 Detection of cell fusion via cytosolic BiFC partners
Plasmids YN-Bach2 and YC-Bach2 were transfected into separate populations of COS-1 cells. CFP–Histone H2A (red) was
co-transfected with YN-Bach2. After induction of fusion, time-lapse imaging was performed. Fusion signals (green) were mainly
found in cytosol and a late joining nucleus was seen, at 12 h 10 min, entering from the lower left corner (arrows).
signals exhibiting behaviour shown in Figures 4(b)
and 4(c), wherein the two signals eventually separate,
were also frequently found (56%+ −8%; see also Sup-
plementaryMoviesS2–S4athttp://www.biolcell.org/
boc/102/boc1020525add.htm). False-positive sig-
nals were signiﬁcantly reduced when putative fusion
was deﬁned as two or more nuclear YFP signals co-
inciding with CFP signals and coupled with bright-
ﬁeld detection and so identiﬁcation of cell borders
(3%+ −1%). Similarly, when ﬂuorescent probes were
used to label different populations, the incidence of
false-positive cell fusion events using ﬂow cytometry
was reported to be as high as 1.53% (Huerta et al.,
2002). The percentage of false-positive events is rel-
atively high if one considers that spontaneous fusion
events may account for 1% of the total number of
cells co-cultured. The limited speciﬁcity of this ap-
proach will also prove troublesome when studying
cell types prone to aggregate (i.e. embryonic stem
cells). For these reasons, an inducible signal is de-
sired for detecting fusion products so that true sig-
nalsdonotneedtobediscriminatedfrombackground
signal.
Inducible systems that employ the Cre–LoxP sys-
tem have been used to study cell fusion (Alvarez-
Dolado et al., 2003; Mohler and Blau, 1996). With
thissystem,aplasmidwithstopcodonﬂankedbytwo
LoxP sites is placed proximal to a reporter gene (i.e.
luciferase). Fusion of a cell harbouring this plasmid
with a cell expressing Cre recombinase results in the
expressionofthereportergene.Inanattempttocom-
parethisinduciblesystemwiththeBiFCapproachto
detectcellfusion,COS-1cellsweretransfectedwitha
plasmidp231pCMVe-betaAc-STOP-luc(containing
aﬂoxedstopcassetteinfrontofaluciferasegene).Sur-
prisingly, COS-1 cells with transfected plasmid alone
(i.e. stop codon in place) showed high levels of luci-
feraseactivity.Thesameplasmidwasusedtotransfect
PAECs (porcine aortic endothelial cells) and showed
no detectable activity for luciferase. The plasmid has
beenshowntohavefunctionalluciferaseactivityonly
aftertheactionofCrerecombinaseinothercelltypes.
These results suggest the Cre–LoxP approach might
not be suitable for some cancer cell lines, which ap-
parentlyexhibitCre-likeactivityorspontaneoussup-
pression of transcription termination.
The other disadvantage of the Cre–LoxP system is
the delay in detection of the fusion event. The Cre–
LoxP system requires time for excision of the stop
codon and proper protein formation. The generation
of BiFC signals also requires some time to form the
ﬂuorescence complex, but can be generated with pre-
existing proteins.
Detection of cell fusion via cytosolic BiFC partners
BiFC proteins can be selected to alter signal location
and signal pattern. As one example, the Bach2 (BTB
andCNChomology1,basicleucinezippertranscrip-
tion factor 2) was employed as a BiFC protein due to
its ability to form homodimers (Oyake et al., 1996)
and its cytosolic distribution (Yoshida et al., 2007).
When YN-Bach2 and YC-Bach2 were transfected in
separate populations of COS-1 cells, inducible sig-
nals were collected using time-lapse microscopy after
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Figure 6 Characterization of chimaeric cells by tracking live fusion products for extended periods
Plasmids YN-CBX5 and YC-CBX5 were transfected into separate populations of COS-1 cells. Fusion signals localized mostly
within nuclei except while hybrids were in the mitotic stage of the cell cycle. The fate of fusion hybrids in terms of proliferation
or death were monitored via time-lapse imaging for 72 h (fusion-BiFC, n=220). To compare the fate of fused hybrids and
their unfused counterparts, the same plasmids were sequentially transfected into a single population of COS-1 cells and
signals generated were monitored for 72 h (transfection of unfused COS-1, n=260). To compare with alternate fusion detection
regimes, YFP and CFP were expressed in separate populations of COS-1 cells and cells with overlapping YFP/CFP signals were
monitored for 72 h (fusion-two colour, n=152). (a) Fate of fusion products. The fraction of fusion products (or unfused COS-1
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Figure 6 (contd)
cells) undergoing proliferation, death or neither was determined over the 72 h period. (b) Fate of proliferating fusion products.
Fusion products detected by BiFC that demonstrated the ability to proliferate (n=26) were further delineated by their abil-
ity or inability to undergo complete cytokinesis. (c–g) Representative time-lapse proﬁle for conditions described in (a, b).
(c) Proliferating fusion-BiFC hybrid. (d) Fusion-BiFC hybrid undergoing cell death. (e) Stable and viable fusion-BiFC hybrid.
(f) Fusion-BiFC hybrid undergoing DNA replication without completion of cytokinesis to form a multinucleate entity. (g) Fu-
sion-BiFC hybrid undergoing DNA replication without apparent cytokinesis to form a cell with a single, giant nucleus. Scale bars
in (a–g), 20 μm; error bars represent S.D.
application of PEG. A small amount of plasmid en-
coding CFP–Histone H2A (red nuclei, Figure 5) was
co-transfected with YN-Bach2 to allow tracking of
nuclei prior to cell fusion. BiFC signals were detec-
ted in the cytosol (green, Figure 5) and allowed clear
visualization of the hybrid border. Typical aggreg-
ation of nuclei at the centre of the fused cell was
observed, but in this case a view of the cytosol
was possible in addition to nuclei. Of note, at least
two nuclei appeared to join the fusion event during
the imaging cycle (see also Supplementary Movie S5
at http://www.biolcell.org/boc/102/boc1020525add.
htm)–perhapstheﬁrstdocumentedcaseoftheevents
leadingtospontaneousfusionoralternativelythemi-
grationofnucleiwithinahybrid(arrowsinFigure5).
Analysis of the characteristics of hybrid cells
detected using BiFC analysis
To investigate the characteristics of chimaeric cells,
we tracked products of cell fusion containing two
or multiple nuclei detected by BiFC analysis over
time. We examined the proliferation of hybrid cells,
rate of cell death and the overall stability of hybrid
cells. We used BiFC subunits linked to the CBX5
chromatin-binding protein as this protein forms ho-
modimers and is enriched within heterochromatic
regions, but is displaced from chromatin during mi-
tosis (Cowieson et al., 2000; Hirota et al., 2005). Us-
ing transfection conditions identical with those used
above, plasmids encoding YN-CBX5 and YC-CBX5
were transfected into separate populations of COS-1
cells and inducible signals were tracked using time-
lapse microscopy after application of PEG. Fusion
products (containing 2–30 nuclei) were categorized
according to cell behaviour over a 72 h time span.
Of note, cells were seeded at a high density to pro-
mote cell–cell contact and subsequent fusion events.
At this seeding density, the growth rate is low and
the death rate is high (see Supplementary Figure S1
at http://www.biolcell.org/boc/102/boc1020525add.
htm). Most of the hybrid cells detected using BiFC
analysis remained stable and viable over the time of
observation (72 h), but did not divide (68%+ −9%,
Figures 6a and 6e; see Supplementary Movie S6
at http://www.biolcell.org/boc/102/boc1020525add.
htm). In hybrid cells, cell death was observed
(21%+ −5%, Figures 6a and 6d; see Supplement-
ary Movie S7 at http://www.biolcell.org/boc/102/
boc1020525add.htm), and in other hybrid cells,
proliferation of nuclei was observed (11%+ −5%,
Figures 6a, 6c, 6f and 6g; see Supplementary
Movies S8–S10 at http://www.biolcell.org/boc/102/
boc1020525add.htm). The frequencies of prolifera-
tion and death were not statistically different from
unfusedcounterparts(COS-1cellssequentiallytrans-
fected with identical BiFC pairs, Figure 6a), indicat-
ingthatcellfusiondoesnotinhibitsurvivalofCOS-1
cells under the conditions used here. This result was
further conﬁrmed as COS-1 fusion products detected
using the two-colour method exhibited statistically
similarproliferation,deathandsurvival(withoutpro-
liferation) rates compared with unfused counterparts
(Figure 6a).
Oftheproliferatinghybrids,somecompletedcyto-
kinesis (69%+ −2%) to produce 2, 3, 4 or more
daughter cells. Within this population, all progeny
inherited uneven nuclear volumes or number. The
other population of hybrids failed to complete cyto-
kinesis (31%+ −2%), and formed either a multi-
nucleate entity or a cell with one giant nucleus.
Hybrids that contained multiple nuclei after pro-
liferation appeared to arise from a regression of the
cleavage furrow during cytokinesis (Shi and King,
2005). Hybrids that formed a giant nucleus showed
no apparent attempt to undergo cytokinesis. These
observations indicate that cell fusion can result in
hybrid cells with many different properties, poten-
tially depending on the characteristics of the parental
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cells or their environments. Further studies of the
effects of cell fusion on the characteristics of hybrid
cells and their biological roles will undoubtedly be
facilitated by BiFC analysis of cell fusion.
Discussion
We report here what we believe to be a substantial
step toward discerning the biological impact of cell
fusion. Because the product of a cell fusion event
can appear unchanged from an unfused counterpart,
a highly speciﬁc approach for detection of cell fu-
sion is necessary. The BiFC-based method described
hereisinducibleandhighlyspeciﬁc,ensuringthatall
signals generated represent actual fusion events. The
BiFC-based method generates a single-colour ﬂuor-
escent signal that grows more intense over time and
can be tracked using a standard ﬂuorescence imaging
system. Further, the BiFC approach allows rapid de-
tection of signals since proteins synthesized prior to
fusion can generate a signal. Rapid signal genera-
tion is crucial for the study of early fusion events. In
contrast, other inducible, single-colour methods, in-
cluding the Cre–LoxP system, require time to excise
the LoxP-containing cassette, initiate transcription,
translation and proper folding of the reporter gene.
In addition, the speciﬁcity of the Cre–LoxP approach
can be compromised if the stop codon can be by-
passed in the absence of Cre or cell fusion. In sum,
the BiFC-based approach offers the ﬁrst rapid, spe-
ciﬁc and relatively simple means to detect cell fusion
for long-term studies.
The beneﬁts of this approach are already appar-
ent. Several decades ago, it was demonstrated that
fusion of tumour cells with lymphocytes yields meta-
static cells (Mekler, 1971) and that cell fusion con-
tributes the phenotypic and genotypic diversity of
tumours (Warner, 1975). However, the mechanistic
details of these processes have been difﬁcult to study
and hence remain largely unknown. Here we mon-
itored fusion among COS-1 cells, a line transformed
by deﬁcient SV40 (simian virus 40) virus via per-
turbationoftumoursuppressors,p53andRb(retino-
blastoma) through large T antigen (Gluzman, 1981).
We show that fusion did not inhibit the ability of
hybrids to proliferate, although not all proliferating
hybrids underwent division (31%+ −2% of prolifer-
ating hybrids). Of those hybrids that did undergo
cytokinesis after proliferation (69%+ −2% of prolif-
erating hybrids), division was asymmetric with pro-
genycontainingunequalnumbersofnucleiorvolume
of nuclei via reductive division (Wang et al., 2003;
Duncan et al., 2009) or other mechanisms. Chro-
mosomal rearrangement inherent in these processes
lends insight into the mechanism whereby fusion
might contribute to the massive chromosomal in-
stability and subsequent genetic diversity of tumour
cells. In addition, we observed that some progeny
of asymmetric division of hybrids being phenotyp-
ically indistinguishable from non-fused counterpart
suggests possible underestimation of the signiﬁcance
of fusion. Consistent with both potential outcomes,
depolyploidization of tumour cells exposed to radi-
ation can give rise to cells capable of proliferation
and uniquely equipped to evade the genotoxic or
cytotoxic agent that initially spurred polyploidy (Tao
et al., 2008; Ianzini et al., 2009). It is tempting
therefore to hypothesize that fusion followed by de-
polyploidizationmayenablecancercellstowithstand
clinical treatments. This hypothesis and others re-
lated to the role of fusion in carcinogenesis will be
facilitated by the BiFC approach described here.
The mechanistic details garnering stem cell–
somatic cell fusion are also a mystery. It is possible
that fusion in this case mimics that of transformed
cells, although the process may be entirely different.
If it is similar, it is interesting to consider the role
of stable, non-proliferative hybrids in stem cell pro-
gramming or somatic cell reprogramming. Perhaps
the quiescent state imposed by fusion (Figure 6e)
allows time needed for (re)programming of fused
nuclei; of note, nuclear reprogramming could start
within one day of fusion (Pereira et al., 2008). A de-
tection method such as BiFC analysis enables robust,
long-term detection of fusion and hence could begin
to disclose mechanistic details of this elusive process.
It is important to consider the limitations of the
BiFC approach so that it can be most effectively and
constructively employed. There may, for example,
be instances when the two-colour method described
above will sufﬁce. The two-colour method provides
strength of detection of fusion events in real time.
And although this method suffers from a substantial
false-positiverate,thisproblembecomeslesssigniﬁc-
ant when fusion events are plentiful. However, when
the timing or location of fusion is unclear and the
frequency is low (i.e. stem cell/cancer cell–somatic
cell fusion), a method such as BiFC analysis could
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be the method of choice. One limitation of the BiFC
methodisthatthesensitivitydependsontransfection
efﬁciency. The higher the efﬁciency, the more sensit-
ivetheapproachislikelytobe.Inthatvein,transient
transfection efﬁciency can only be estimated prior to
fusion and so it is difﬁcult to determine or compare
the frequency of cell fusion between different fusion
partners.However,itwouldbepossibletoutilizeabi-
cistronic construct including a reporter to simultan-
eously measure transfection efﬁciency. Alternatively,
it would be possible to generate stable transformants
or utilize viral transduction to circumvent this prob-
lem. Another limitation of this approach is the pos-
sibility that the formation of the BIFC complex may,
under certain circumstances, be irreversible (Tarassov
et al., 2008). The possibility that BiFC complexes
may form irreversible complexes could limit or en-
hance the utility of the BiFC assay. In one way, the
irreversible nature of the complex could increase
long-term stability of the signal and hence enhance
the overall sensitivity of the assay. Alternatively, ir-
reversible formation of the BiFC complex might
indirectly impact on cell phenotype and function
and hence should be carefully tested before long-
termtrackingexperiments.Toalleviatethispotential
drawback, a BiFC pair with high turnover rate might
be selected. Finally, it might be possible for a BiFC
signal to be generated as a consequence of uptake of
cell debris and so generate a false-positive BiFC sig-
nal.However,ourresultsindicatethatthispossibility
is rare since a BiFC signal generated from uptake of
debris would correspond to a cell with a single nuc-
leus. In all co-cultures described here, BiFC signals
detected immediately after mixing fusion always cor-
responded to cells with two or more nuclei.
The nature of the BiFC system is extremely versat-
ile since selected protein interactions can include any
ofthousandsofdocumentedproteininteractions.One
can therefore envision not only detecting cell fusion,
but also studying protein–protein interactions relev-
anttotheinitiation,propagationor(re)programming
eventsassociatedwithcellfusion.Inaddition,acom-
bination with other variants of ﬂuorescent proteins
could be used to perform multicolour BiFC (Hu et
al.,2002).Inthiscase,morethantwoproteininterac-
tions or more than two cellular populations could be
studied. In such a case, ﬂuorescence signals acquired
throughdifferentchannelscouldrepresentuniquefu-
sion events or unique consequences of fusion events.
Finally, ﬂuorescent fragments could be linked to a
membrane protein pair facing either the cytosolic or
extracellular side to discriminate fusion events from
cell–cell contact and to indicate the location of the
fusion pore (Shi et al., 2009). Taken together,
the BiFC approach will enable us to gain new in-
sights into a poorly understood cellular process.
Materials and methods
Cell culture
COS-1 cells were maintained in high-glucose DMEM
(Dulbecco’s modiﬁed Eagle’s medium) supplemented with 1%
L-glutamine, sodium pyruvate, 10% (v/v) FBS (fetal bovine
serum) and antibiotics at 37◦Ci n5 %C O 2.
Transfection
COS-1 cells were transfected with different BiFC constructs at
0.5–2 μg per well of a 6-well plate by FuGENETM 6 (Roche).
The ratio of DNA to reagent was kept at 1:3. Cells were kept
in a medium containing transfecting material until further pre-
paration for co-culturing the two transfectants. For comparison
with unfused COS-1 cells, we sequentially transfected cells with
BiFC pairs under identical transfection conditions as those in
corresponding experiments.
Live cell imaging
All images were acquired by Nikon TE300, Nikon Diaphot
200 or Olympus IX71 inverted ﬂuorescence microscope with a
cooled CCD (charge-coupled-device) camera. YFP ﬂuorescence
was measured by excitation at 500 nm and emission at 535 nm.
CFP ﬂuorescence was measured by excitation at 436 nm and
emission at 470 nm. Fluorescence images were obtained every
10 min for a period of 8–72 h. Prior to image acquisition, fusion
hybridsexpressingYN-andYC-fusionproteinsrequiredincub-
ation at 30◦C for 1 h to induce maturation of ﬂuorophore. Cells
weremaintainedinCO2-independentmedium(Gibco)whileac-
quiringimagesat30◦C(NikonTE300)or37◦Cestablishedbya
heated stage (Olympus IX71). Long-term multiposition ﬂuores-
cence studies were conducted on a Nikon Diaphot 200 equipped
with a heated (37◦C) chamber, Hamamatsu Orca camera and
motorized XY stage (Applied Scientiﬁc MS-2000). Cells were
imaged in 6-well plates and image acquisition was controlled
by μManager software (Vale Lab; University of California-San
Francisco).
Generation of BiFC constructs
BiFC constructs were generated as follows: constructs of
YC-Histone H3.1, VN-CBX2 were described previously
(Vincenz and Kerppola, 2008). CFP–c1 is from Invitrogen. For
VN-Histone H3.1, the amino acids 1–172 of Venus were fused
totheN-terminusofhumanHistoneH3.1derivedbyPCRfrom
an EST (expressed sequence tag). Primers for PCR ampliﬁcation
of Histone H3.1 were as follows: forward primer: 5 - TAGGCT-
CTAGAGCAGTCTCTGCGCGTACGAAGCAGACTGCTCG-
3 ; reverse primer: 5 -CACCCGGGATCCTCATCAAGCCCT-
CTCGCCGCGGATACGACGTGCG-3 .F o rY F P - ,Y N - C B X 5
or YC-CBX5, full-length YFP, the amino acids 1–172 of YFP
(YN) or the amino acids 173–238 of YFP (YC) were fused to the
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N-terminus of human CBX5. Primers for PCR ampliﬁcation
of human CBX5 using an EST as the template were as
follows: forward primer, 5 -TAGGCTCTAGAGCAGTCT-
CTATGGGAAAGAAAACCAAGCGGACAG-3 ; reverse pri-
mer, 5 -TAGGCTCTAGAGCAGTCTCTATGGGAAAGAAA-
ACCAAGCGGACAG-3 . The amino acid sequence shown
below denotes the linker bridging ﬂuorescent protein, VN-,
YN- or YC- fragments to N-terminal fusion proteins (i.e.
Histone H3.1): Asn-Ser-Ser-Ile-Asp-Leu-Ile-Ser-Val-Pro-Val-
Asp-Ser-Arg-Ala-Val-Ser. CFP–Histone H2A was constructed
using a similar strategy and was provided by Dr Mohamed
Aittaleb (Life Sciences Institute, University of Michigan, Ann
Arbor, MI, U.S.A.). Plasmids encoding YN- or YC-Bach2 were
YFP fragments (amino acids 1–172 or 173–238) fused to the
N-terminus of Bach2 (ampliﬁed from murine origin) and were
provided by Dr Nirmala Rajaram (Department of Biological
Chemistry, University of Michigan, Ann Arbor, MI, U.S.A.).
Plasmid requests regarding BiFC plasmids and YFP–HP1
should be addressed to Dr Claudius Vincenz or Dr Tom K.
Kerppola.
The plasmid p231 pCMVe-betaAc-STOP-luc (containing a
ﬂoxed stop cassette in front of a luciferase gene) was constructed
in Dr Jeffrey Green’s laboratory (Laboratory of Cell Biology and
Genetics, National Institutes of Health, Bethesda, MD, U.S.A.)
and obtained from Addgene (Kaczmarczyk and Green, 2001).
Cell fate determination
Unfused COS-1 cells or PEG-induced hybrids were tracked us-
ing the imaging system described above for 72 h. During image
analysis, cells exhibiting membrane blebbing and subsequent
shrinkageaswellasroundedmorphologywerecategorizedascell
death. Cells exhibiting sudden relocation of CBX5 and disap-
pearanceofnuclearbordersfollowedwithorwithoutcompletion
ofsubsequentcytokinesiswerecharacterizedascellproliferation.
Cells lacking signs of either death or proliferation were placed
in a third category. A total of 40–70 hybrids were analysed per
experiment and three independent experiments were performed.
Two micrograms of each plasmid was used either for fusion ex-
perimentsorfortransfectingunfusedcounterparts.Since2 μgof
plasmids is the maximum amount possible per transfection, se-
quential transfection of YN-CBX5 or YC-CBX5 was employed
in transfecting unfused counterparts.
PEG-induced fusion
Cells were transfected by expression constructs indicated in each
experiment overnight. Typically, transfectants expressing
each BiFC counterpart were mixed in a 1:1 ratio and co-cultured
overnight. After incubation, co-cultured cells were washed once
with PBS, and fusion was induced by applying PEG1500 (50%,
v/v) directly on culture dishes or slides for 60 s, washed twice
with cell culture media and maintained in cell culture media
thereafter. Fluorescence signals were monitored by the described
inverted ﬂuorescence microscopy system.
Statistical analyses
For comparison of proliferation, death and cellular stability of
fusion products and unfused counterparts, a normal distribution
was assumed and one-way ANOVA and Student’s t test for un-
pairedsampleswereused.DatawereanalysedwithJMP5.0.1for
Windows (SAS Institute, Carey, NC, U.S.A.). A 95% (P<0.05)
conﬁdence interval was applied for statistical signiﬁcance.
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Figure S1 Growth rate of COS-1 cells seeded at high
density
COS-1 cells used for fusion experiments were seeded at
high-density (∼95%) conﬂuency. At this conﬂuency, the cells
are in plateau phase and so undergo minimal net growth dur-
ing the period of time typically monitored for cell fusion (i.e. 1–
4 days after seeding). Shown here is a typical growth curve
(from three separate experiments) for COS-1 cells at the con-
ﬂuency used for cell fusion experiments, although BiFC trans-
duction and fusion were not induced in this case. Arrow indic-
ates typical time point for induction of fusion (d1) after mixing
of BiFC transfected populations (d0).
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